...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: "expert market"??

fuzzy if it makes any difference to you, all I hold is "ZHCLF" shares as I got in RVX post SPINCO. Bought them through iTRADE & Investorline. I received proxy votes from both houses for "ZHCLF", Zenith Capital Corp.

 

Koo

 

Share
New Message
Please login to post a reply